COVID-19 AND HEPATIC DYSFUNCTION- A PROSPECTIVE STUDY ON THE SEVERITY OF THE DISEASE

Santosh Kumar  Nayan; Santosh  Kumar; Abhay  Kumar; Anand  Dev; Siddharth  Singh

doi:10.51168/sjhrafrica.v5i12.1445

Authors

Santosh Kumar Nayan Associate Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,
Santosh Kumar Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,
Abhay Kumar Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,
Anand Dev Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,
Siddharth Singh Associate Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India

DOI:

https://doi.org/10.51168/sjhrafrica.v5i12.1445

Keywords:

COVID-19, Liver dysfunction, Association, severity

Abstract

Background

A patient who died due to respiratory failure suffering from COVID-19 revealed severe liver injuries in the postmortem. This indicated that the virus starts affecting other organs of the body simultaneously with the respiratory system. Around 23% of the patients who suffered due to COVID-19 had liver injuries. This study has been conducted to determine the relationship between liver injuries with COVID-19 and also to determine the severity of COVID-19 when liver injuries are reported.

Method

This was a cross-sectional study conducted prospectively to determine the correlation between liver dysfunction and the severity of COVID-19. The study was carried out for 6 months at IGIMS, Patna in Bihar, India. 150 patients above the age of 18 years suffering from COVID-19 were considered for this study. Liver function tests and tests for inflammatory markers were carried out and the patients were monitored thoroughly during hospitalization and one month later.

Results

95 patients among the 150 had severe COVID and the remaining 55 had moderate COVID-19. The patients who had moderate COVID-19 infection had around 80% survival rate whereas the patients with severe COVID-19 infection had a 30% survival rate. The non-survivors and those with severe COVID-19 had a higher occurrence of liver dysfunction. Also, it was found that liver enzymes had a substantial association with the presence of inflammatory markers.

Conclusion

This study reported higher levels of liver enzymes in the patients infected with COVID-19 indicating its association. Overall liver dysfunction was prominent among the non-survivors and those who had severe COVID-19. Also, a significant relationship was derived between inflammatory markers and the occurrence of liver dysfunction.

Recommendation

Doctors should monitor inflammatory markers and liver function as well to check the prognosis of the disease in elderly individuals suffering from COVID-19.

Author Biographies

Santosh Kumar, Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,

Anand Dev, Assistant Professor, Department of Trauma and Emergency, IGIMS, Patna, Bihar, India,

References

Zhu NA , Zhang D , Wang W , Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. doi:10.1056/NEJMoa2001017. https://doi.org/10.1056/NEJMoa2001017

Gorbalenya AE , Baker SC , Baric RS , de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses statement of the coronavirus study group. Bio Rxivorg 2020;1-15. doi:10.1101/2020.02.07.937862. https://doi.org/10.1101/2020.02.07.937862

WHO director-general's opening remarks at the media briefing on COVID-19. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s- opening-remarks-at-the-media-briefing-on-COVID-19-11-march-2020 Accessed on 1st August 2023.

WHO Coronavirus Disease. (COVID-19) dashboard. Available at https://COVID19.who.int/ Accessed on 1st August 2023

Aleem A, Shah H. Gastrointestinal and Hepatic Manifestations of Coronavirus (COVID-19) [Updated 2022 May 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570562/

Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020;1-13. doi:10.1101/2020.02.03.931766. https://doi.org/10.1101/2020.02.03.931766

Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R, et al.Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int 2020;14:711-22. https://doi.org/10.1007/s12072-020-10071-9

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5. https://doi.org/10.1016/S0140-6736(20)30183-5

Guan WJ , Ni ZY , Hu Y , Liang WH, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20. doi: 10.1056/NEJMoa2002032

https://doi.org/10.1056/NEJMoa2002032

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-2. doi: 10.1016/S2213-2600 (20)30076-X https://doi.org/10.1016/S2213-2600(20)30076-X

Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: abnormal liver function tests. J Hepatol 2020;73:566-574.doi: 10.1016/j.jhep.2020.04.006 https://doi.org/10.1016/j.jhep.2020.04.006

Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol2020;5:428-30. doi: 10.1016/S2468-1253 (20)30057-1 https://doi.org/10.1016/S2468-1253(20)30057-1

Ali N. Relationship between COVID-19 infection and liver injury: a review of recent data. Frontiers in medicine 2020;7:458.doi: 10.3389/fmed.2020.00458. https://doi.org/10.3389/fmed.2020.00458

Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al.Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol 2020;92:1902-14. doi: 10.1002/jmv.25884.

https://doi.org/10.1002/jmv.25884

Satapathy SK, Kuntzen C, Qiu H, Jiang Y, Bodenheimer HC, Roth NC, et al. The severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality. Eur J Gastroenterol Hepatol 2021;33(1S Suppl 1):e320-e328. https://doi.org/10.1097/MEG.0000000000002055